Healthcare -
Biotechnology - NASDAQ - US
$ 38.6444
-0.118 %
$ 10.8 B
Market Cap
21.96
P/E
Price Target
Average
--17.59%
Revenue Forecast
Estimate
10.00%
EBIT
Estimate
--0.75%
Net Income
Estimate
22.60%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Exelixis, Inc.
Wall Street analysts predict an average 1-year price target for EXEL of $31.8 , with forecasts ranging from
a
low of
$18 to a high of $42 .
EXEL Lowest Price Target
Wall Street Target
18 USD
-53.42%
EXEL Average Price Target
Wall Street Target
31.8 USD
-17.59%
EXEL Highest Price Target
Wall Street Target
42 USD
8.68%
REVENUE FORECAST
Revenue Forecast Chart EXEL
EBIT FORECAST
EBIT Forecast Chart EXEL
NET INCOME FORECAST
Net Income Chart EXEL